Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Successful treatment of Aspergillus ventriculitis through voriconazole adaptive pharmacotherapy, immunomodulation, and therapeutic monitoring of cerebrospinal fluid (1→3)-β-D-glucan.

Autor: Chen TK; Pediatric Infectious Diseases, Department of Pediatrics, Miller Children's and Women's Hospital, Long Beach, CA, USA.; University of California, Irvine, Irvine, CA, USA., Groncy PK; Hematology-Oncology, Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Javahery R; Neurosurgery, Long Beach Memorial Medical Center, Miller Children's and Women's Hospital, Long Beach, CA, USA., Chai RY; Radiology, Long Beach Memorial Medical Center, Miller Children's and Women's Hospital, Long Beach, CA, USA., Nagpala P; Endocrinology, Department of Pediatrics, Miller Children's and Women's Hospital, Long Beach, CA, USA., Finkelman M; Associates of Cape Cod, Inc., East Falmouth, MA, USA., Petraitiene R; Transplantation-Oncology Infectious Diseases Program and Infectious Diseases Translational Research Laboratory, Division of Infectious Diseases, Weill Cornell Medicine, New York, NY, USA., Walsh TJ; Transplantation-Oncology Infectious Diseases Program and Infectious Diseases Translational Research Laboratory, Division of Infectious Diseases, Weill Cornell Medicine, New York, NY, USA thw2003@med.cornell.edu.; Departments of Pediatrics, and Microbiology & Immunology, Weill Cornell Medicine, New York, NY, USA.

Publikováno v: Medical mycology [Med Mycol] 2017 Jan 01; Vol. 55 (1), pp. 109-117. Date of Electronic Publication: 2016 Nov 12.